Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes. 1998

J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
Laboratoire de Physiologie Cellulaire Respiratoire, Contrat de Recherche Institut National de la Santé et de la Recherche Médicale 9806, Université Bordeaux 2, 33076 Bordeaux, France.

The effect of endothelin (ET)-1 on both cytosolic Ca2+ concentration ([Ca2+]i) and membrane current in freshly isolated myocytes, as well as on the contraction of arterial rings, was investigated in rat main pulmonary artery (RMPA) and intrapulmonary arteries (RIPA). ET-1 (5-100 nM, 30 s) induced a first [Ca2+]i peak followed by 3-5 oscillations of decreasing amplitude. In RMPA, the ET-1-induced [Ca2+]i response was fully abolished by BQ-123 (0.1 microM). In RIPA, the response was inhibited by BQ-123 in only 21% of the cells, whereas it was abolished by BQ-788 (1 microM) in 70% of the cells. In both types of arteries, the response was not modified in the presence of 100 microM La3+ or in the absence of external Ca2+ but disappeared after pretreatment of the cells with thapsigargin (1 microM) or neomycin (0.1 microM). In RPMA myocytes clamped at -60 mV, ET-1 induced an oscillatory inward current, the reversal potential of which was close to the equilibrium potential for Cl-. This current was unaltered by the removal of external Ca2+ but was abolished by niflumic acid (50 microM). In arterial rings, the ET-1 (100 nM)-induced contraction was decreased by 35% in the presence of either niflumic acid (50 microM) or nifedipine (1 microM). These results demonstrate that ET-1 via the ETA receptor only in RMPA and both ETA and ETB receptors in RIPA induce [Ca2+]i oscillations due to iterative Ca2+ release from an inositol trisphosphate-sensitive Ca2+ store. Ca2+ release secondarily activates an oscillatory membrane Cl- current that can depolarize the cell membrane, leading to an influx of Ca2+, this latter contributing to the ET-1-induced vasoconstrictor effect.

UI MeSH Term Description Entries
D007537 Isometric Contraction Muscular contractions characterized by increase in tension without change in length. Contraction, Isometric,Contractions, Isometric,Isometric Contractions
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D009544 Niflumic Acid An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. Donalgin,Flunir,Niflactol,Niflugel,Nifluril,Acid, Niflumic
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D009991 Oscillometry The measurement of frequency or oscillation changes. Oscillometries
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular

Related Publications

J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
February 2008, American journal of physiology. Lung cellular and molecular physiology,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
January 2014, Global cardiology science & practice,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
November 2001, American journal of physiology. Lung cellular and molecular physiology,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
October 2007, British journal of pharmacology,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
October 1992, Biochimica et biophysica acta,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
August 2000, American journal of physiology. Lung cellular and molecular physiology,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
September 1993, The Journal of physiology,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
September 2022, International journal of molecular sciences,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
January 2010, Current medicinal chemistry,
J M Hyvelin, and C Guibert, and R Marthan, and J P Savineau
June 2011, Pharmacological research,
Copied contents to your clipboard!